We have modeled the transition from acute to chronic pain in the rat. In this model (termed hyperalgesic priming) a chronic state develops after a prior inflammatory process or exposure to an inflammatory mediator, in which response to subsequent exposure to prostaglandin E 2 (PGE 2 ) is characterized by a protein kinase Ce-dependent marked prolongation of mechanical hyperalgesia. To assess the effect of priming on the function of the nociceptor, we have performed in vitro patch clamp and in vivo single-fiber electrophysiology studies using tumor necrosis factor a to induce priming. In vitro, the only change observed in nociceptors cultured from primed animals was a marked hyperpolarization in resting membrane potential (RMP); prolonged sensitization, measured at 60 minutes, could not be tested in vitro. However, complimentary with behavioral findings, in vivo baseline mechanical nociceptive threshold was significantly elevated compared to controls. Thirty minutes after injection of PGE 2 into the peripheral receptive field, both primed and control nociceptors showed enhanced response to mechanical stimulation. However, 60 minutes after PGE 2 administration, the response to mechanical stimulation was further increased in primed but not in control nociceptors. Thus, at the level of the primary afferent nociceptor, it is possible to demonstrate both altered function at baseline and prolonged PGE 2 -induced sensitization. Intrathecal antisense (AS) to K v 7.2, which contributes to RMP in sensory neurons, reversibly prevented the expression of priming in both behavioral and single-fiber electrophysiology experiments, implicating these channels in the expression of hyperalgesic priming. Ó
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Introduction
To study mechanisms underlying the transition from acute to chronic pain, we developed a model in the rat, termed hyperalgesic priming, induced by exposure of the peripheral terminal of the primary afferent nociceptor to inflammatory mediators [1, 36] . Exposure (via intradermal injection) to these inflammatory mediators, such as tumor necrosis factor alpha (TNFa) [33] or interleukin 6 (IL-6) [14]), produces a long-lasting neuroplastic change in nociceptor function, well beyond the hyperalgesia induced by these agents, which is observed as enhanced and markedly prolonged mechanical hyperalgesia in response to a subsequent exposure to an inflammatory mediator (eg, by prostaglandin E 2 [PGE 2 ] [1]). In subsequent studies, we demonstrated that this prolongation of the hyperalgesia induced by the pronociceptive inflammatory cytokine PGE 2 was mediated by protein kinase-C epsilon (PKCe) [34] ; protein kinase A (PKA) mediates the shorter-duration (30-minute) prostaglandin E 2 (PGE 2 ) hyperalgesia in the control animal, and a similar period of time in the primed animal [1] . In these behavioral studies, altered function in the primary afferent nociceptor was inferred by two techniques. The first, reversal (of the longer-duration enhancement of PGE 2 hyperalgesia) by spinal intrathecal administration of antisense to signaling molecules implicated in priming [22, 34] , demonstrates that the sensory neuron is the fundamental unit in priming. Secondly, peripheral administration of an inhibitor of PKCe at the site of nociceptive testing demonstrates the dependence of the expression of hyperalgesic priming on this intracellular signaling pathway [1] .
To more directly evaluate the physiological changes in the nociceptor produced in the primed state, we performed in vitro patch clamp and in vivo single-fiber electrophysiology studies of primary afferent nociceptor function to determine the electrophysiological
